BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 15869535)

  • 1. Lifestyle of Nordic people with psoriasis.
    Davidsson S; Blomqvist K; Molin L; Mørk C; Sigurgeirsson B; Zachariae H; Zachariae R
    Int J Dermatol; 2005 May; 44(5):378-83. PubMed ID: 15869535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality of life in patients with psoriasis: the contribution of clinical variables and psoriasis-specific stress.
    Fortune DG; Main CJ; O'Sullivan TM; Griffiths CE
    Br J Dermatol; 1997 Nov; 137(5):755-60. PubMed ID: 9415236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physical and psychologic measures are necessary to assess overall psoriasis severity.
    Kirby B; Richards HL; Woo P; Hindle E; Main CJ; Griffiths CE
    J Am Acad Dermatol; 2001 Jul; 45(1):72-6. PubMed ID: 11423838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age, gender, quality of life and psychological distress in patients hospitalized with psoriasis.
    Sampogna F; Chren MM; Melchi CF; Pasquini P; Tabolli S; Abeni D;
    Br J Dermatol; 2006 Feb; 154(2):325-31. PubMed ID: 16433804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measuring quality of life of patients with different clinical types of psoriasis using the SF-36.
    Sampogna F; Tabolli S; Söderfeldt B; Axtelius B; Aparo U; Abeni D;
    Br J Dermatol; 2006 May; 154(5):844-9. PubMed ID: 16634884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psoriasis has a major secondary impact on the lives of family members and partners.
    Eghlileb AM; Davies EE; Finlay AY
    Br J Dermatol; 2007 Jun; 156(6):1245-50. PubMed ID: 17459044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. European patient perspectives on the impact of psoriasis: the EUROPSO patient membership survey.
    Dubertret L; Mrowietz U; Ranki A; van de Kerkhof PC; Chimenti S; Lotti T; Schäfer G;
    Br J Dermatol; 2006 Oct; 155(4):729-36. PubMed ID: 16965422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of vitiligo on self-reported health-related quality of life.
    Ongenae K; Van Geel N; De Schepper S; Naeyaert JM
    Br J Dermatol; 2005 Jun; 152(6):1165-72. PubMed ID: 15948977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between smoking and the clinical severity of psoriasis.
    Fortes C; Mastroeni S; Leffondré K; Sampogna F; Melchi F; Mazzotti E; Pasquini P; Abeni D
    Arch Dermatol; 2005 Dec; 141(12):1580-4. PubMed ID: 16365261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The psoriasis disability index in Chinese patients: contribution of clinical and psychological variables.
    Yang Y; Koh D; Khoo L; Nyunt SZ; Ng V; Goh CL
    Int J Dermatol; 2005 Nov; 44(11):925-9. PubMed ID: 16336525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suffering in psoriasis patients: its relation with illness severity and subjective well-being.
    Reimus JL; Vingerhoets AJ; Soons PH; Korstanje MJ
    Int J Dermatol; 2007 Oct; 46(10):1042-5. PubMed ID: 17910711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sexual dysfunction in patients with psoriasis.
    Türel Ermertcan A; Temeltaş G; Deveci A; Dinç G; Güler HB; Oztürkcan S
    J Dermatol; 2006 Nov; 33(11):772-8. PubMed ID: 17073992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infliximab treatment results in significant improvement in the quality of life of patients with severe psoriasis: a double-blind placebo-controlled trial.
    Feldman SR; Gordon KB; Bala M; Evans R; Li S; Dooley LT; Guzzo C; Patel K; Menter A; Gottlieb AB
    Br J Dermatol; 2005 May; 152(5):954-60. PubMed ID: 15888152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developing a quality of life instrument in patients with psoriasis: the Psoriasis Quality of Life Questionnaire (PQLQ).
    Inanir I; Aydemir O; Gündüz K; Danaci AE; Türel A
    Int J Dermatol; 2006 Mar; 45(3):234-8. PubMed ID: 16533221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Alexithymia and psoriasis: a case-control study of 53 patients].
    Masmoudi J; Maalej I; Masmoudi A; Rached H; Rebai A; Turki H; Jaoua A
    Encephale; 2009 Feb; 35(1):10-7. PubMed ID: 19250988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disease severity, quality of life and health care in plaque-type psoriasis: a multicenter cross-sectional study in Germany.
    Augustin M; Krüger K; Radtke MA; Schwippl I; Reich K
    Dermatology; 2008; 216(4):366-72. PubMed ID: 18319601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of quality of life in patients with psoriasis: a study from Serbia.
    Milčić D; Janković S; Vesić S; Milinković M; Janković J
    Int J Dermatol; 2015; 54(5):523-8. PubMed ID: 24738764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding the relationship between objective disease severity, psoriatic symptoms, illness-related stress, health-related quality of life and depressive symptoms in patients with psoriasis - a structural equations modeling approach.
    Schmitt J; Ford DE
    Gen Hosp Psychiatry; 2007; 29(2):134-40. PubMed ID: 17336662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of patients with psoriasis vulgaris vs. psoriatic arthritis with regard to the reported quality of life].
    Rüschenschmidt C; Somberg B; Häussler G; Lohmann J
    Rehabilitation (Stuttg); 2008 Dec; 47(6):343-9. PubMed ID: 19085795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of the stigmatization experience of psoriasis patients: a 1-year follow-up of the illness and its psychosocial consequences in men and women.
    Schmid-Ott G; Künsebeck HW; Jäger B; Sittig U; Hofste N; Ott R; Malewski P; Lamprecht F
    Acta Derm Venereol; 2005; 85(1):27-32. PubMed ID: 15848987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.